HTAi DISINVESTMENT & EARLY AWARENESS INTEREST GROUP Business - - PowerPoint PPT Presentation

HTAi DISINVESTMENT & EARLY AWARENESS INTEREST GROUP Business Meeting

June 18, 2019 18:00-19:00 (CET) session IG09

Agenda

1: Welcome and introductions of Executive Team 2: Interest group activities 3: Topic submission for next funding cycle 4: Introduction of incoming chairs 5: EuroScan activities 6: Disinvestment toolkit 7: WHO decommissioning book 8: Questions 9: Adjournment

Chairs: Julie Polisena and Vigdis Lauvrak Executive Committee: Rosmin Esmail, Roberta Joppi, Iñaki Gutierreza Ibarluzea, Hans-Peter Dauben, Brian Godman Technical Officer: Anna Lien Espeland

Disinvestment and Early Awareness IG Executive Team

Interest Group Activities

• Disinvestment Toolkit
• Survey on Disinvestment Activities & Candidates in the

HTA Community

• Current Awareness Alerts

Interest Group Activities: Peer-Reviewed Publication

Interest Group Activities: Current Awareness Alerts

• New research on disinvestment and early awareness
• Single awareness service
• Systematic and comprehensive literature searches

Topic Submission for Next Funding Cycle

• Collaboration with IGs or external groups
• Topic relevant to HTA community
• Funding proposal
• Submission deadline in summer 2019

Introduction of Incoming Chairs Chair: Rosmin Esmail Vice-Chair: Antonio Migliore New Executive Team Member: Pricivel Carrera

Update on the EuroScan activities

Antonio Migliore

AGENAS, Italian national agency for regional healthcare Scientific Director of EuroScan International Network

EuroScan International Network

Established in 1997 as a collaborative international network of public agencies; Acquired legal status (nonprofit) in 2017. A scientific non-profit association aimed to:  Collect and share information on emerging, new and obsolete health technologies.  Be the main global forum for the development of methods to identify emerging, new and obsolete health technologies.  Support and promote early awareness systems. Services Internal Affairs External Partnerships

 Methodological Toolkit for new and emerging technologies ---> Available in:  Methodological Toolkit for disinvestment ---> Work in progress (with HTAi);  EuroScan website www.euroscan.org ---> Platform to manage information sharing among member;  EuroScan Database ---> Redesign is ongoing (new elements such as ICHI codes);  News feed ---> Metasearch in a list of selected sources.

Update on Services Update on Internal Affairs

 Periodic Scientific Meetings ---> Spring & Autumn + General Assembly (during HTAi);  Working Groups ---> WG-MT for medical technologies; WG-PT for pharmaceuticals;

• Sources for identification of new and emerging technologies
• Definition of the new EuroScan Database structure
• Member profiling

 Health Interventions and Technologies Journal (HInT)

MoU between EuroScan and relevant partners

 WHO; HTAi; INAHTA; RedeTSa; HTAsiaLink ---> Survey on disinvestment with HTAi.

Partnerships within EU Horizon 2020 research and innovation programme

SAFE-N-MEDTECH - Safety testing in the life cycle of nanotechnology-enabled medical technologies for health

https://cordis.europa.eu/project/rcn/221200/factsheet/en

 Aimed to build an innovative open access platform to offer to companies and reference laboratories, the capabilities, know-how, networks and services required for the development, testing, assessment, up-scaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices.  27 partners; 2019-2023; EU contribution: 14 billion EUR

EU-PEARL - EU Patient-cEntric clinicAl tRial pLatform

https://eu-pearl.eu/

 Aimed to create a reusable, accessible and sustainable modular integrated research platform (IRP) in Europe for the design and execution

• f patient-centric, platform trials not limited to one compound or company and to set up an open, dynamic patient inclusive governance

structure necessary to deliver the appropriate regulatory, ethical, legal, statistical and data utilisation requirements of the IRP. Four case- study: Major Depressive Disorder, Tuberculosis, Non-Alcoholic Steatohepatitis, and Neurofibromatosis.  36 partners; 2019-2023; EU contribution: 26 billion EUR

Update on External Partnerships

Disinvestment Toolkit

WHO Decommissioning Book

• WHO medical device technical series
• Chapter on disinvestment
• Anticipated publication in summer 2019

Questions

Adjournment

Email: interestgroups@htai.org Webpage: https://htai.org/interest-groups/disinvestment-and- early-awareness/